In this review
Separate an available prescription from a planned test
The homepage says its personalised programme begins with testing of 40-plus biomarkers. The dedicated at-home blood-testing page, however, is marked coming soon and asks readers to join a waitlist. Its proposed provider-reviewed panels do not establish that a kit is currently orderable or included in every medication plan. Ask which monitoring is actually available now and which outside tests would need separate payment. [1] [2]
The current product pages identify an NAD+ injection and oral compounded sermorelin troches alongside compounded weight-care offers. These are different preparations and clinical questions. Neither a biomarker count nor a broad longevity catalogue demonstrates that buying several treatments improves healthy lifespan. I would choose one purpose and ask what result would justify continuing. [3] [4] [5] [6]
Consider what a measurement can establish with our biological-age testing evidence review.
Each starting price carries its own prepaid term
NAD+ injection starts at $235 per month with two months paid upfront; oral sermorelin starts at $199 with three months prepaid. Compounded semaglutide advertises a $158 equivalent under a two-month buy-one/get-one promotion, while tirzepatide’s $325 equivalent requires six months. Confirm the complete selected payments; rounded equivalents, crossed-out figures and promotions are not reliable renewal invoices. [3] [4] [5] [6]
The product pages do not establish complete formula, concentration, count and quantity for every selected preparation. A troche is not an injection, and the standalone NAD+ offer is not interchangeable with a possible GLP-1 additive. Broader programme content also does not establish private dietitian appointments or a complete prepaid laboratory panel. [3] [4] [5] [6]
Separate confirmed calendar-month care fees and testing costs using the health-service cost planner.
Clinical and dispensing detail matters more than a quality badge
Alan is a technology platform working with independent physician networks and pharmacies. A platform name,503A/503B label or general potency-testing claim does not independently verify the actual assigned clinician, facility, batch or result. Compounded drugs do not receive FDA premarket review for safety, effectiveness or quality. Ask for the complete preparation and a monitoring plan tied to the intended clinical question. [3] [4] [5] [6] [8] [9]
Support lists staff hours of 9 am to 5 pm Eastern on weekdays, distinct from unlimited online access or an immediate clinical reply. Its current state list is specific to compounded semaglutide; do not use it as a universal NAD+, sermorelin or catalogue eligibility map. Clinical suitability and product availability need confirmation for the individual. [7]
Compare another provider’s preparation and monitoring disclosures in our Coby Health service-scope review.
Renewal timing and current-order cancellation are different
Payment is collected upfront and support promises a full refund for physician nonapproval. Once review is submitted and approved order processing begins, cancellation is unavailable; prescription sales are final. Partial-term refunds are not promised, though exceptions may be discretionary. Obtain the problem-reporting route without assuming that delivery delays or disappointing results create an automatic remedy. [7] [8]
The first renewal may process five business days early and later cycles can move forward operationally. Section 14 requires cancellation three business days before processing; later wording instead uses three days before term start. Use the stricter actual-processing deadline and keep confirmation. A paused plan may resume billing automatically. My assessment would rest on a defined care need and affordable commitment, not the breadth of the menu. [8]
Assess one clinical purpose and complete commitment in the health-service comparison.
Compare another provider’s actual processing deadline and financial terms in our Amble plan and cancellation review.
Understanding the cost
NAD+ injection starts at $235/month with two months prepaid; oral sermorelin $199/month with three months prepaid. Semaglutide’s $158 equivalent requires a two-month promotion; tirzepatide $325/month requires six months prepaid. These are separate services, not a combined package. Confirm full invoices, monitoring costs and actual renewal processing dates.
Build your cost estimateSources
- Alan Health: programme scope and biomarker marketing
- Alan Health: at-home lab testing page marked coming soon
- Alan Health: current NAD+ injection and two-month prepayment
- Alan Health: oral sermorelin troches and three-month plan
- Alan Health: compounded semaglutide promotion and preparation
- Alan Health: compounded tirzepatide and six-month prepayment
- Alan Health: current billing, nonapproval, processing and support answers
- Alan Health: complete April 7, 2025 subscription and payment terms
- FDA: understanding the risks of compounded drugs
This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.